MBIO
MBIO
NASDAQ · Biotechnology

Mustang Bio Inc

$0.59
0.00 (-0.08%)
As of Aug 15, 2:38 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,640.5% upside
Low Target $6.34
Average Target $10.33
High Target $12.82
Current Price $0.59
Current
$0.59
Target
$10.33
$6.34 $10.33 avg $12.82
Scenario Analysis
Bear Case
$6.34
968.2%
Low target
Base Case
$10.33
+1,640.5%
Avg target
Bull Case
$12.82
+2,060.1%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$1.88
-68.4% from high
52-Week Low
$0.53
+13.0% from low
Target vs 52W High
$10.33
+449.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.4%